21 CFR Part 11: (Un)Expected Added Value

, ,
BioPharm International, BioPharm International-02-01-2002, Volume 15, Issue 2
Pages: 44-50

By Joseph F. Noferi, Esq., Ralph Dillon, and Daniel E. Worden, pp. 44-50. Implementing the ERES rule will do more than make your organization compliant with federal regulations. It will strengthen its intellectual property position for the information age.